ResearcherSecond Xiangya Hospital of Central South UniversityNo recent work listed
Daxiong Xiang
Matched on ORCID iD 0000-0002-4226-6574; OpenAlex author ID A5004821939, A5108558189.
Their work
Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.
- Pancreatic cancer papers
- 3 (first author 0, last author 2)
- Pancreatic cancer trials
- 0
- Pancreatic cancer grants
- 0
- Labs led
- 1
- Collaborators
- 3
2020: 2 papers · 2021: 1 paper
Papers 3
- Comparative evaluation of methods for isolating small extracellular vesicles derived from pancreatic cancer cells. Co-author DOI 10.1186/s13578-021-00550-3↗
- Gemcitabine loaded autologous exosomes for effective and safe chemotherapy of pancreatic cancer. Last author DOI 10.1016/j.actbio.2019.10.022↗
- Emerging nanomedicine-based strategies for preventing metastasis of pancreatic cancer. Last author DOI 10.1016/j.jconrel.2020.01.041↗
Closest collaborators
The 3 strongest of 3 ranked by shared papers, trials and grants, with recent and small-team work weighing most.
- Yongjiang Li · 3 shared papers, 2020–2021
- Paper Emerging nanomedicine-based strategies for preventing metastasis of pancreatic cancer. DOI 10.1016/j.jconrel.2020.01.041↗
- Paper Comparative evaluation of methods for isolating small extracellular vesicles derived from pancreatic cancer cells. DOI 10.1186/s13578-021-00550-3↗
- Paper Gemcitabine loaded autologous exosomes for effective and safe chemotherapy of pancreatic cancer. DOI 10.1016/j.actbio.2019.10.022↗
- Jiemin Wang · 3 shared papers, 2020–2021
- Paper Emerging nanomedicine-based strategies for preventing metastasis of pancreatic cancer. DOI 10.1016/j.jconrel.2020.01.041↗
- Paper Comparative evaluation of methods for isolating small extracellular vesicles derived from pancreatic cancer cells. DOI 10.1186/s13578-021-00550-3↗
- Paper Gemcitabine loaded autologous exosomes for effective and safe chemotherapy of pancreatic cancer. DOI 10.1016/j.actbio.2019.10.022↗
- Wen-Qun Li · 1 shared paper, 2021
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.